NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/12/2022
Back to search
Official data from USPTO
NEOHOMEOPATHY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NEOHOMEOPATHY
ST13
US500000085431718Class
5
Filing
85431718
Registration
4201169
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
03/12/2022
Trademark type
Word
Nice classes
5
Filing date
09/26/2011
Registration date
09/04/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/12/2022
Last transaction
03/12/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
02/05/1998
First use in commerce
02/05/1998
Drawing code
4
Owner type
03
Owner location
Woodbine, IA, US
Examiner
LAW, CHRISTOPHER M
Law office
L30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Liddell Laboratories, Inc.
Representatives
Daniel W. Roberts Law Offices of Daniel W. Roberts
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Homeopathic pharmaceuticals for use in the treatment of Respiratory conditions; stress fatigue and emotional conditions; skeletal and connective tissue conditions; digestive and intestinal conditions; neurological conditions; blood and circulatory conditions; skin conditions; infectious diseases; allergic conditions; female gynecologicalhormone and reproductive conditions; organ therapy; balancing the immune system and hormone production; viral infections; bacterial infections; inflammation; chronic disorders; degenerative disorders; environment pollution and detoxification conditions; painheadachemigraine and neuralgia; low energy levels due to viral infections or imbalances of glandular functions; insomnia; smoking withdrawal; weight loss; all for human use.; Homeopathic supplements
Publications
History of USPTO decisions and trademark events.
31 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/12/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/12/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/12/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
10/26/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
09/04/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/11/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/11/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/10/2017
E815
TEAS SECTION 8 & 15 RECEIVED
10/17/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/17/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/04/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
09/04/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/19/2012
PUBO
PUBLISHED FOR OPPOSITION
06/19/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/30/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/14/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/10/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/09/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/09/2012
ALIE
ASSIGNED TO LIE
04/30/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/20/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/11/2012
GNRT
NON-FINAL ACTION E-MAILED
01/11/2012
CNRT
NON-FINAL ACTION WRITTEN
01/11/2012
DOCK
ASSIGNED TO EXAMINER
01/10/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/29/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/29/2011
APET
ASSIGNED TO PETITION STAFF
09/29/2011
TRMS
TEAS REQUEST TO MAKE SPECIAL RECEIVED
09/29/2011
NWAP
NEW APPLICATION ENTERED
09/29/2011
Continuous trademark protection
Get notified about every new filing that threatens NEOHOMEOPATHY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.